Back to top

Fund Update: New $24.6M $ASND stock position opened by SAPIENT CAPITAL LLC

SAPIENT CAPITAL LLC has opened a new $24.6M position in $ASND, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 06-30-2026 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $ASND.

$ASND Hedge Fund Activity

We have seen 131 institutional investors add shares of $ASND stock to their portfolio, and 150 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$ASND Insider Trading Activity

ASND Insider Trades

$ASND insiders have traded $ASND stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $ASND stock by insiders over the last 6 months:

  • JEAN JACQUES BIENAIME has made 5 purchases buying 900 shares for an estimated $206,682 and 0 sales.
  • SCOTT THOMAS SMITH (EVP & Chief Financial Officer) has made 2 purchases buying 350 shares for an estimated $77,730 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$ASND Analyst Ratings

Wall Street analysts have issued reports on $ASND in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • B of A Securities issued a "Buy" rating on 01/30/2026

To track analyst ratings and price targets for $ASND, check out Quiver Quantitative's $ASND forecast page.

$ASND Price Targets

Multiple analysts have issued price targets for $ASND recently. We have seen 9 analysts offer price targets for $ASND in the last 6 months, with a median target of $292.0.

Here are some recent targets:

  • Luca Issi from RBC Capital set a target price of $280.0 on 07/07/2026
  • Eric Joseph from Citigroup set a target price of $355.0 on 05/19/2026
  • Josh Schimmer from Evercore ISI Group set a target price of $329.0 on 05/15/2026
  • Eliana Merle from Barclays set a target price of $345.0 on 05/11/2026
  • Derek Archila from Wells Fargo set a target price of $326.0 on 05/08/2026
  • Tazeen Ahmad from B of A Securities set a target price of $292.0 on 04/16/2026
  • Yun Zhong from Wedbush set a target price of $273.0 on 04/09/2026

Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.

Check out Quiver Quantitative's $ASND ticker page for more data.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Ascendis Pharma A/S (ASND)